1.The Klippel-Trenaunay syndrome: case report.
Myung Sik PARK ; Chun Su PARK ; Seung Hwan LEE
The Journal of the Korean Orthopaedic Association 1991;26(4):1350-1353
No abstract available.
Klippel-Trenaunay-Weber Syndrome*
2.Dilatation of Severe Corrosive Esophageal Stricture Guided by Right Coronary Artery Catheter.
Sang In LEE ; Seung Hwan SHN ; In Suh PARK ; Heung Jai CHOI
Korean Journal of Gastrointestinal Endoscopy 1991;11(1):77-80
Nonoperative dilatation techniques such as bougination, balloon dilatation, endoscopic laser therapy, and endoscopic electro-coagulation, have been applied to relieve dysphagia due to esophageal strictures, but the most widly used ia peroral dilatation once a guide wire has been passed under direct vision using a fiberoptic endoscope. Some cases of severe and curved esophageal strictures coutd'nt be introduced the conventional steel guide wire. We desecibe a method of cannulation of these difficult strictures guided by torque control angiographic catheter with radiogrphic control. A case of 18 year old man with severe corrosive esophageal stricture ingested HCl was successfully treated with esophageal dilatation with Savary-Gilliard dilator guided by Judkin's right coronary artery catheter.
Adolescent
;
Catheterization
;
Catheters*
;
Constriction, Pathologic
;
Coronary Vessels*
;
Deglutition Disorders
;
Dilatation*
;
Endoscopes
;
Esophageal Stenosis*
;
Humans
;
Laser Therapy
;
Steel
;
Torque
3.A case of aspergillosis in the mastoid antrum.
Hwan Koo LEE ; Seung Hwan LEE ; Chul Won PARK ; Kyung Sung AHN
Korean Journal of Otolaryngology - Head and Neck Surgery 1993;36(5):1060-1064
No abstract available.
Aspergillosis*
;
Mastoid*
5.Subperiosteal Composite Xenograft(Kiel bone) with Autologous Red Marrow for a Fibrous Dysplasia
Chang Ju LEE ; Seung Rim PARK ; Sung Kee CHANG ; Jeong Hwan OH ; Seong Soo PARK
The Journal of the Korean Orthopaedic Association 1987;22(2):559-563
The courses of the progression in the fibrous dysplasia are characterized by asymptomatic progression or spontaneous regression in some cases after the growth has ceased and the aims of treatment for a fibrous dysplasia are prevention of the pathologic fractures and correction of the deformities. The osteogenic potentiality of the cambium layer in the periosteum and the beneficial effect on the osteogenesis of the impregnating bone graft with autologous red marrow are well documented. We experienced an extensive fibrous dysplasia with cortical thinning and pathologic fracture and it was managed with subperiosteal combined xenograft of Kiel bone with autologous red marrow for the induction of cortical thickening and prevention of the pathologic fractures because of the inoperability of curettage due to extensive lesion over the entire femur, limitations in obtaining large amount of autogenous cancellous bone for the graft and lack of the facilities of the bone bank. This subperiosteal composite xenograft with autologous red marrow for a fibrous dysplasia gave an excellent result of a remarkable cortical thickening and we think this can be a type of management for a entensive fibrous dysplasia. So we are reporting this case with bibliographic reviews.
Bone Banks
;
Bone Marrow
;
Cambium
;
Congenital Abnormalities
;
Curettage
;
Femur
;
Fractures, Spontaneous
;
Heterografts
;
Osteogenesis
;
Periosteum
;
Transplants
6.Pathological Findings of the Femoral Head in Avasular Necrosis after Failed Core - Decompression Surgery.
Yoon Soo PARK ; Won Hwan OH ; Seung Rim YI ; Min Jong PARK ; Yeon Lim SUH
The Journal of the Korean Orthopaedic Association 1997;32(3):547-553
Core decompression is still widely used in avascular necrosis of the femoral head but the results are unpredictable and the indications are not settled yet. The reparative process of the decompressed femoral head is poorly understood. Seven cases in 5 patients were undertaken THRA following failed decompression and these were studied for the radiological and pathological changes of the core tracts. The lesions of failed cases were involved more than 1/3 of femoral head on MRI and all cases were stage II A or B. The extent of the necrotic area in MRI was enlarged with crack, sclerosis and sometimes gas collection. Depression of the subchondral plates were also observed. Capillary ingrowth or neovascularization was not found at all and there were only fibrosis, inflammatory response and foreign body reactions.
Capillaries
;
Decompression*
;
Depression
;
Fibrosis
;
Foreign Bodies
;
Head*
;
Humans
;
Magnetic Resonance Imaging
;
Necrosis*
;
Sclerosis
7.Amisulpride-Induced Hyperprolactinemia:Preliminary Study.
Jung Woo LEE ; Young Min PARK ; Seung Hwan LEE ; Seung Gul KANG ; Bun Hee LEE ; Eunjin PARK
Korean Journal of Psychosomatic Medicine 2011;19(1):41-47
OBJECTIVE: Hyperprolactinemia is common side effect associated with antipsychotics use. Nevertheless, hyperprolactinemia is relatively neglected by clinician. Especially, there is no study related to amisulpride-induced hyperprolactinemia in korea. This study aimed to determine whether amisulpride can be induced hyperprolactinemia in Korean psychiatric patients. METHODS: This study methodology consisted of a retrospective review of medical charts and prolactin levels. Serum prolactin levels were measured in 24 Korean patients(12 males and 12 females) with psychosis who were treated over 400mg of amisulpride per day. RESULTS: All patients had hyperprolactinemia. Prolactin levels significantly increased after receiving amisulpride(z=-3.702, p=0.000). The prolactin level was significantly higher in females(156.29+/-63.75ng/mL) than in males(69.04+/-39.91ng/mL) after administering amisulpride(p=0.000). There was a correlation between dosage and prolactin levels(r=0.61, p=0.002). However, there was no correlation between duration of treatment and prolactin levels. CONCLUSIONS: Antipsychotics, especially amisulpride can increase serum prolactin levels and may results in short and long term side effects. Routine clinical assessment of initial and additional prolactin level and associated symptoms should be done.
Antipsychotic Agents
;
Humans
;
Hyperprolactinemia
;
Korea
;
Male
;
Prolactin
;
Psychotic Disorders
;
Retrospective Studies
;
Sulpiride
8.Effectiveness of Intramuscular Stimulation Therapy in Patients with Osteoarthritis of the Knee Joint.
Young Kyu PARK ; Jong Woong WOO ; Seung Lyul ANN ; Jeong A KIM ; Do Kyung YOUN ; Seung Hoi PARK ; Kyung Hwan CHO
Journal of the Korean Geriatrics Society 2001;5(4):318-328
BACKGROUND: Osteoarthritis(OA) has become one of the most important medical problem among the old age because it causes severe functional disability, but, up to date, the therapeutic methods for OA have not been so satisfactory to the patients with OA. Authors have investigated the effectiveness of intramuscular stimulation(IMS) therapy as an substitutive therapy for the relief of pain and dysfunction in patients with OA of the knee. METHODS: Eighteen patients who had visited the department of family medicine, Korea university anam hospital, with symptomatic OA of the knee during the period from March 1 to May 31. 2001 were included in this study and treated with IMS therapy on the quadriceps and hamstring muscles four times during two weeks. Patients self-scored Korean Western Ontario and McMaster universities Osteoarthritis Index (KWOMAC) at baseline and after the last therapy. The result was analysed by paired t-test and ANOVA. RESULT: Patients improved on KWOMAC scales for pain, stiffness, function and total scores after IMS therapy(p<0.05). The demographic characteristics such as body mass index (BML), duration of disease, affected site, radiologic finding did not have influence on the result of this study. No adverse effects of IMS therapy were reported. CONCLUSION: In this study, the improvement of pain, stiffness, and function of knee joint after treatment was reported. This study suggest that IMS is an effective and safe substitutive therapy for patients with OA of Knee.
Body Mass Index
;
Humans
;
Knee Joint*
;
Knee*
;
Korea
;
Muscles
;
Ontario
;
Osteoarthritis*
;
Weights and Measures
9.Evaluation of an ELISA kit for the Serodiagnosis of Pulmonary Tuberculosis by Using Mixed Antigens of Mycobacterium Tuberculosis.
Seung Kyu PARK ; Phil Ho KIM ; Seung Chul KIM ; In Hwan CHOI ; Sun Dae SONG ; Sang Nae CHO
Tuberculosis and Respiratory Diseases 2000;49(5):558-567
BACKGROUND: Recently, serologic techniques for tuberculosis have been developed and some of them, which are focusing on detection of serum antibodies mainly directed against specific 38-kDa Mycobacterium tuberculosis, have already been introduced into the market. In this study, diagnostic significance of a new serologic test(ELISA kit) for pulmonary tuberculosis was evaluated. METHODS: Serologic test with newly developed ELISA kit was performed upon 474 individuals, who include 333 active pulmonary tuberculosis patients, 80 healthy cases, and 61 tuberculosis contact cases. This serologic test was based on the ELISA technique and designed to detect antibodies to mixed complex antigens including 38-kDa, which were developed by Erume Biotech Co.,Seoul.Active pulmonary tuberculosis was diagnosed by sputum AFB smear and culture methods. RESULTS: The seropositivities using this ELISA kit were 82.1% and 73.6% in smear-positive and negative groups among active pulmonary tuberculosis, respectively. And, it also showed that seronegativities were 97.5% and 85.2% in healthy and contact groups, respectively. As a whole, the results of our study suing the ELISA kit as a diagnostic methiod for pulmonary tuberculosis showed 80.0% sensitivity for active pulmonary tuberculosis, 97.5% specificity, 96.1% positive predictive value, and 65.0% negative predictive value when the prevalence of tuberculosis in the samples was 60.1%. CONCLUSION: Our results reveal that the detection of antibody its reaction with 38-kDa antigen of M.tuberculosis is not sufficient to be accepted as single diagnostic method for pulmonary tuberculosis. However, they suggest that ELISA kit may be considered as an adjunctive test to standard diagnostic techniques of pulmonary tuberculosis.
Antibodies
;
Enzyme-Linked Immunosorbent Assay*
;
Humans
;
Mycobacterium tuberculosis*
;
Mycobacterium*
;
Prevalence
;
Sensitivity and Specificity
;
Serologic Tests*
;
Sputum
;
Tuberculosis
;
Tuberculosis, Pulmonary*
10.Cross-resistance Between Rifampicin and Rifabutin and Its Relationship with rpoB Gene Mutations in Clinically Isolated MDR-TB Strains.
Byoung Ju KIM ; Seung Hwan OH ; Eun Jin CHO ; Seung Kyu PARK
Tuberculosis and Respiratory Diseases 2006;60(2):171-179
BACKGROUND: Despite the emerging danger of MDR-TB to human beings, there have only been a limited number of drugs developed to treat MDR-TB since 1970. This study investigated the cross-resistance rate between rifampicin (RFP) and rifabutin (RBU) in order to determine the efficacy of rifabutin in treating MDR-TB. In addition, the results of rifabutin were correlated with the rpoB mutations, which are believed to be markers for MDR-TB and RFP resistance. METHODS: The MICs of RBU were tested against 126 clinical isolates of MDR-TB submitted to the clinical laboratory of National Masan TB Hospital in 2004. Five different concentrations (10-160 microgram/ml) were used for the MICs. The detection of the rpoB mutations was performed using a RFP resistance detection kit with a line probe assay(LiPA), which contains the oligonucleotide probes for 5 wide type and 3 specific mutations (513CCA, 516GTC, and 531TTG). The rpoB mutation was determined by direct sequencing. RESULTS: The rate of cross-resistance between RFP and RBU was 70.5%(74/105) at 20 microgram/ml RBU(ed note: How much RFP?) Most mutations (86.3%) occurred in the 524~534 codons. The His526Gln, His526Leu, Leu533Pro, Gln513Glu, and Leu511Pro mutations(Ed note: Is this correct?) were associated with the susceptibilty to RBU. CONCLUSION: Based on the cross-resistance rate between RFP and RBU, RBU may be used effectively in some MDR-TB patients. Therefore, a conventional drug susceptibility test for RBU and a determination of the critical concentration are needed. However, rpoB gene mutation test may be have limited clinical applications in detecting RBU resistance.
Codon
;
Humans
;
Oligonucleotide Probes
;
Rifabutin*
;
Rifampin*